(2S,4R)-1-(4-Chlorophenylsulfonyl)-4-(4-chlorophenylsulfonylamino)-2-[(E)-2-(3-methoxycarbonylphenyl)vinyl]pyrrolidine | 121147-44-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2S,4R)-1-(4-Chlorophenylsulfonyl)-4-(4-chlorophenylsulfonylamino)-2-[(E)-2-(3-methoxycarbonylphenyl)vinyl]pyrrolidine
• 英文别名: methyl 3-[(E)-2-[(2S,4R)-1-(4-chlorophenyl)sulfonyl-4-[(4-chlorophenyl)sulfonylamino]pyrrolidin-2-yl]ethenyl]benzoate
• CAS: 121147-44-2
• 化学式: C₂₆H₂₄Cl₂N₂O₆S₂
• 分子量: 595.524
• InChiKey: PUMIMBRIQBVRIW-HIPQDABWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  38
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  127
• 氢给体数：
  1
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  (2S,4R)-1-(4-Chlorophenylsulfonyl)-4-(4-chlorophenylsulfonylamino)-2-[(E)-2-(3-methoxycarbonylphenyl)vinyl]pyrrolidine 在 sodium hydroxide 作用下， 以 甲醇 、 水 为溶剂， 反应 4.0h， 以312 mg的产率得到3-((E)-2-((2S,4R)-1-((4-chlorophenyl)sulfonyl)-4-(((4-chlorophenyl)sulfonyl)amino)pyrrolidin-2-yl)ethenyl)benzoic acid
  参考文献：
  名称：

  Synthesis and Biological Activity of 1-Phenylsulfonyl-4-Phenylsulfonylaminopyrrolidine Derivatives as Thromboxane A 2 Receptor Antagonists

  摘要：

  The synthesis and biological activity of novel 1-phenylsulfonyl-4- phenylsulfonylaminopyrrolidine analogues are described. All compounds were produced through modification of the substituent formally corresponding to the 1,3-dioxane ring system and the omega-octenol side chain of thromboxane A(2) (TXA(2)), in reference to the structure of Daltroban. Several compounds were found to be potent TXA(2) receptor antagonists. Compound 51a was the most effective inhibitor of 9.11-epoxymethano PGH(2) (U-46619)-induced rat aortic strip contraction (IC50 = 0.48 nM). (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(01)00397-2
• 作为产物：
  描述：

  (2S,4R)-BOC-4-苯甲酰氧基脯氨酸甲酯 在 palladium on activated charcoal sodium azide 、 氢气 、 sodium hydride 、 二异丁基氢化铝 、 potassium carbonate 、 三乙胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 吡啶 、 甲醇 、 二氯甲烷 、 水 、 二甲基亚砜 、 甲苯 为溶剂， -78.0~90.0 ℃ 、303.98 kPa 条件下， 反应 21.5h， 生成 (2S,4R)-1-(4-Chlorophenylsulfonyl)-4-(4-chlorophenylsulfonylamino)-2-[(E)-2-(3-methoxycarbonylphenyl)vinyl]pyrrolidine
  参考文献：
  名称：

  Synthesis and Biological Activity of 1-Phenylsulfonyl-4-Phenylsulfonylaminopyrrolidine Derivatives as Thromboxane A 2 Receptor Antagonists

  摘要：

  The synthesis and biological activity of novel 1-phenylsulfonyl-4- phenylsulfonylaminopyrrolidine analogues are described. All compounds were produced through modification of the substituent formally corresponding to the 1,3-dioxane ring system and the omega-octenol side chain of thromboxane A(2) (TXA(2)), in reference to the structure of Daltroban. Several compounds were found to be potent TXA(2) receptor antagonists. Compound 51a was the most effective inhibitor of 9.11-epoxymethano PGH(2) (U-46619)-induced rat aortic strip contraction (IC50 = 0.48 nM). (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(01)00397-2

文献信息

• Pyrrolidine derivatives
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP0289911A2

  公开（公告）日：1988-11-09

  A compound of the formula : wherein     R¹ is hydrogen or an acyl group,     R² is an acyl group,     R³ is carboxy(lower)alkyl, lower alkyl substituted with carboxy and one or more halogen atom(s), protected carboxy(lower)alkyl, carboxyaryl, protected carboxyaryl, carboxy, protected carboxy, hydroxy(lower)­alkyl, sulfino(lower)alkyl, phosphono(lower)alkyl, protected phosphono(lower)alkyl or halo(lower)­alkyl,     R⁷ is hydrogen or lower alkyl, and     A is (in which R⁸ is hydrogen or lower alkyl), and a pharmaceutically acceptable salt thereof, processes for its preparation and pharmaceutical compositions comprising them. The invention also relates to intermediates of the formula and process for production thereof.

  式中的化合物 其中 R¹ 是氢或酰基、 R² 是酰基 R³ 是羧基（低级）烷基、被羧基和一个或多个卤原子取代的低级烷基、受保护的羧基（低级）烷基、羧基芳基、受保护的羧基芳基、羧基、受保护的羧基、羟基（低级）烷基、亚磺酰基（低级）烷基、膦酰基（低级）烷基、受保护的膦酰基（低级）烷基或卤代（低级）烷基、 R⁷ 是氢或低级烷基，以及 A 是 (其中 R⁸ 是氢或低级烷基）、 及其药学上可接受的盐、制备工艺和包含它们的药物组合物。本发明还涉及式 及其生产工艺。
• US4916152A
  申请人：——

  公开号：US4916152A

  公开（公告）日：1990-04-10